Davos CH - Search Results

1

Complement system modulation as a target for treatment of arrhythmogenic cardiomyopathy.

Mavroidis M, Davos CH, Psarras S, Varela A, C Athanasiadis N, Katsimpoulas M, Kostavasili I, Maasch C, Vater A, van Tintelen JP, Capetanaki Y. Mavroidis M, et al. Among authors: davos ch. Basic Res Cardiol. 2015 May;110(3):27. doi: 10.1007/s00395-015-0485-6. Epub 2015 Apr 8. Basic Res Cardiol. 2015. PMID: 25851234

2

Standardised Exercise Prescription for Patients with Chronic Coronary Syndrome and/or Heart Failure: A Consensus Statement from the EXPERT Working Group.

Hansen D, Beckers P, Neunhäuserer D, Bjarnason-Wehrens B, Piepoli MF, Rauch B, Völler H, Corrà U, Garcia-Porrero E, Schmid JP, Lamotte M, Doherty P, Reibis R, Niebauer J, Dendale P, Davos CH, Kouidi E, Spruit MA, Vanhees L, Cornelissen V, Edelmann F, Barna O, Stettler C, Tonoli C, Greco E, Pedretti R, Abreu A, Ambrosetti M, Braga SS, Bussotti M, Faggiano P, Takken T, Vigorito C, Schwaab B, Coninx K. Hansen D, et al. Among authors: davos ch. Sports Med. 2023 Nov;53(11):2013-2037. doi: 10.1007/s40279-023-01909-x. Epub 2023 Aug 30. Sports Med. 2023. PMID: 37648876

3

Desmin mediates TNF-alpha-induced aggregate formation and intercalated disk reorganization in heart failure.

Panagopoulou P, Davos CH, Milner DJ, Varela E, Cameron J, Mann DL, Capetanaki Y. Panagopoulou P, et al. Among authors: davos ch. J Cell Biol. 2008 Jun 2;181(5):761-75. doi: 10.1083/jcb.200710049. J Cell Biol. 2008. PMID: 18519735 Free PMC article.

4

Regulation of adverse remodelling by osteopontin in a genetic heart failure model.

Psarras S, Mavroidis M, Sanoudou D, Davos CH, Xanthou G, Varela AE, Panoutsakopoulou V, Capetanaki Y. Psarras S, et al. Among authors: davos ch. Eur Heart J. 2012 Aug;33(15):1954-63. doi: 10.1093/eurheartj/ehr119. Epub 2011 Apr 26. Eur Heart J. 2012. PMID: 21525025

5

Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation.

Salagianni M, Galani IE, Lundberg AM, Davos CH, Varela A, Gavriil A, Lyytikäinen LP, Lehtimäki T, Sigala F, Folkersen L, Gorgoulis V, Lenglet S, Montecucco F, Mach F, Hedin U, Hansson GK, Monaco C, Andreakos E. Salagianni M, et al. Among authors: davos ch. Circulation. 2012 Aug 21;126(8):952-62. doi: 10.1161/CIRCULATIONAHA.111.067678. Epub 2012 Jul 11. Circulation. 2012. PMID: 22787112

6

Tumor necrosis factor-α confers cardioprotection through ectopic expression of keratins K8 and K18.

Papathanasiou S, Rickelt S, Soriano ME, Schips TG, Maier HJ, Davos CH, Varela A, Kaklamanis L, Mann DL, Capetanaki Y. Papathanasiou S, et al. Among authors: davos ch. Nat Med. 2015 Sep;21(9):1076-84. doi: 10.1038/nm.3925. Epub 2015 Aug 17. Nat Med. 2015. PMID: 26280121 Free PMC article.

7

Elevated expression of mechanosensory polycystins in human carotid atherosclerotic plaques: association with p53 activation and disease severity.

Varela A, Piperi C, Sigala F, Agrogiannis G, Davos CH, Andri MA, Manopoulos C, Tsangaris S, Basdra EK, Papavassiliou AG. Varela A, et al. Among authors: davos ch. Sci Rep. 2015 Aug 19;5:13461. doi: 10.1038/srep13461. Sci Rep. 2015. PMID: 26286632 Free PMC article.

8

Peptide-Drug Conjugate GnRH-Sunitinib Targets Angiogenesis Selectively at the Site of Action to Inhibit Tumor Growth.

Argyros O, Karampelas T, Asvos X, Varela A, Sayyad N, Papakyriakou A, Davos CH, Tzakos AG, Fokas D, Tamvakopoulos C. Argyros O, et al. Among authors: davos ch. Cancer Res. 2016 Mar 1;76(5):1181-92. doi: 10.1158/0008-5472.CAN-15-2138. Epub 2015 Dec 8. Cancer Res. 2016. PMID: 26645560

9

Desmin and αB-crystallin interplay in the maintenance of mitochondrial homeostasis and cardiomyocyte survival.

Diokmetzidou A, Soumaka E, Kloukina I, Tsikitis M, Makridakis M, Varela A, Davos CH, Georgopoulos S, Anesti V, Vlahou A, Capetanaki Y. Diokmetzidou A, et al. Among authors: davos ch. J Cell Sci. 2016 Oct 15;129(20):3705-3720. doi: 10.1242/jcs.192203. Epub 2016 Aug 26. J Cell Sci. 2016. PMID: 27566162 Free PMC article.

10

Targeting of the breast cancer microenvironment with a potent and linkable oxindole based antiangiogenic small molecule.

Argyros O, Karampelas T, Varela A, Asvos X, Papakyriakou A, Agalou A, Beis D, Davos CH, Fokas D, Tamvakopoulos C. Argyros O, et al. Among authors: davos ch. Oncotarget. 2017 Jun 6;8(23):37250-37262. doi: 10.18632/oncotarget.16763. Oncotarget. 2017. PMID: 28422745 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters